Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1996 Apr 1;133(1):185–197. doi: 10.1083/jcb.133.1.185

Partial laminin alpha2 chain restoration in alpha2 chain-deficient dy/dy mouse by primary muscle cell culture transplantation

PMCID: PMC2120785  PMID: 8601607

Abstract

Laminin-2 is a component of skeletal and cardiac basal lamina expressed in normal mouse and human. Laminin alpha2 chain (LAMA2), however, is absent from muscles of some congenital muscular dystrophy patients and the dystrophia muscularis (dy/dy) mouse model. LAMA2 restoration was investigated following cell transplantation in vivo in dy/dy mouse. Allogeneic primary muscle cell cultures expressing the beta- galactosidase transgene under control of a muscular promoter, or histocompatible primary muscle cell cultures, were transplanted into dy/dy mouse muscles. FK506 immunosuppression was used in noncompatible models. All transplanted animals expressed LAMA2 in these immunologically-controlled models, and the degrees of LAMA2 restoration were shown to depend on the age of the animal at transplantation, on muscle pretreatment, and on duration time after transplantation in some cases. LAMA2 did not always colocalize with new or hybrid muscle fibers formed by the fusion of donor myoblasts. LAMA2 deposition around muscle fibers was often segmental and seemed to radiate from the center to the periphery of the injection site. Allogeneic conditionally immortalized pure myogenic cells expressing the beta-galactosidase transgene were characterized in vitro and in vivo. When injected into FK506- immunosuppressed dy/dy mice, these cells formed new or hybrid muscle fibers but essentially did not express LAMA2 in vivo. These data show that partial LAMA2 restoration is achieved in LAMA2-deficient dy/dy mouse by primary muscle cell culture transplantation. However, not all myoblasts, or myoblasts alone, or the muscle fibers they form are capable of LAMA2 secretion and deposition in vivo.

Full Text

The Full Text of this article is available as a PDF (8.7 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andre F., Filippi P., Feracci H. Merosin is synthesized by thyroid cells in primary culture irrespective of cellular organization. J Cell Sci. 1994 Jan;107(Pt 1):183–193. doi: 10.1242/jcs.107.1.183. [DOI] [PubMed] [Google Scholar]
  2. Anton E. S., Sandrock A. W., Jr, Matthew W. D. Merosin promotes neurite growth and Schwann cell migration in vitro and nerve regeneration in vivo: evidence using an antibody to merosin, ARM-1. Dev Biol. 1994 Jul;164(1):133–146. doi: 10.1006/dbio.1994.1186. [DOI] [PubMed] [Google Scholar]
  3. Asselin I., Tremblay M., Vilquin J. T., Guérette B., Roy R., Tremblay J. P. Quantification of normal dystrophin mRNA following myoblast transplantation in mdx mice. Muscle Nerve. 1995 Sep;18(9):980–986. doi: 10.1002/mus.880180909. [DOI] [PubMed] [Google Scholar]
  4. Bradley W. G., Jenkison M. Abnormalities of peripheral nerves in murine muscular dystrophy. J Neurol Sci. 1973 Feb;18(2):227–247. doi: 10.1016/0022-510x(73)90009-9. [DOI] [PubMed] [Google Scholar]
  5. Burgeson R. E., Chiquet M., Deutzmann R., Ekblom P., Engel J., Kleinman H., Martin G. R., Meneguzzi G., Paulsson M., Sanes J. A new nomenclature for the laminins. Matrix Biol. 1994 Apr;14(3):209–211. doi: 10.1016/0945-053x(94)90184-8. [DOI] [PubMed] [Google Scholar]
  6. Campbell K. P. Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell. 1995 Mar 10;80(5):675–679. doi: 10.1016/0092-8674(95)90344-5. [DOI] [PubMed] [Google Scholar]
  7. Dubowitz V., Fardeau M. Proceedings of the 27th ENMC sponsored workshop on congenital muscular dystrophy. 22-24 April 1994, The Netherlands. Neuromuscul Disord. 1995 May;5(3):253–258. doi: 10.1016/0960-8966(95)90011-x. [DOI] [PubMed] [Google Scholar]
  8. Ehrig K., Leivo I., Argraves W. S., Ruoslahti E., Engvall E. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci U S A. 1990 May;87(9):3264–3268. doi: 10.1073/pnas.87.9.3264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Engvall E., Earwicker D., Day A., Muir D., Manthorpe M., Paulsson M. Merosin promotes cell attachment and neurite outgrowth and is a component of the neurite-promoting factor of RN22 schwannoma cells. Exp Cell Res. 1992 Jan;198(1):115–123. doi: 10.1016/0014-4827(92)90156-3. [DOI] [PubMed] [Google Scholar]
  10. Engvall E. Laminin variants: why, where and when? Kidney Int. 1993 Jan;43(1):2–6. doi: 10.1038/ki.1993.2. [DOI] [PubMed] [Google Scholar]
  11. Grounds M., Partridge T. A., Sloper J. C. The contribution of exogenous cells to regenerating skeletal muscle: an isoenzyme study of muscle allografts in mice. J Pathol. 1980 Dec;132(4):325–341. doi: 10.1002/path.1711320404. [DOI] [PubMed] [Google Scholar]
  12. Guérette B., Asselin I., Vilquin J. T., Roy R., Tremblay J. P. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mdx mice. Muscle Nerve. 1995 Jan;18(1):39–51. doi: 10.1002/mus.880180107. [DOI] [PubMed] [Google Scholar]
  13. Hallauer P. L., Bradshaw H. L., Hastings K. E. Complex fiber-type-specific expression of fast skeletal muscle troponin I gene constructs in transgenic mice. Development. 1993 Nov;119(3):691–701. doi: 10.1242/dev.119.3.691. [DOI] [PubMed] [Google Scholar]
  14. Hayashi Y. K., Engvall E., Arikawa-Hirasawa E., Goto K., Koga R., Nonaka I., Sugita H., Arahata K. Abnormal localization of laminin subunits in muscular dystrophies. J Neurol Sci. 1993 Oct;119(1):53–64. doi: 10.1016/0022-510x(93)90191-z. [DOI] [PubMed] [Google Scholar]
  15. Hayashi Y. K., Koga R., Tsukahara T., Ishii H., Matsuishi T., Yamashita Y., Nonaka I., Arahata K. Deficiency of laminin alpha 2-chain mRNA in muscle in a patient with merosin-negative congenital muscular dystrophy. Muscle Nerve. 1995 Sep;18(9):1027–1030. doi: 10.1002/mus.880180918. [DOI] [PubMed] [Google Scholar]
  16. Helbling-Leclerc A., Zhang X., Topaloglu H., Cruaud C., Tesson F., Weissenbach J., Tomé F. M., Schwartz K., Fardeau M., Tryggvason K. Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet. 1995 Oct;11(2):216–218. doi: 10.1038/ng1095-216. [DOI] [PubMed] [Google Scholar]
  17. Huard J., Verreault S., Roy R., Tremblay M., Tremblay J. P. High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. J Clin Invest. 1994 Feb;93(2):586–599. doi: 10.1172/JCI117011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jat P. S., Noble M. D., Ataliotis P., Tanaka Y., Yannoutsos N., Larsen L., Kioussis D. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991 Jun 15;88(12):5096–5100. doi: 10.1073/pnas.88.12.5096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kinoshita I., Huard J., Tremblay J. P. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve. 1994 Sep;17(9):975–980. doi: 10.1002/mus.880170903. [DOI] [PubMed] [Google Scholar]
  20. Kinoshita I., Vilquin J. T., Gravel C., Roy R., Tremblay J. P. Myoblast allotransplantation in primates. Muscle Nerve. 1995 Oct;18(10):1217–1218. [PubMed] [Google Scholar]
  21. Kinoshita I., Vilquin J. T., Guérette B., Asselin I., Roy R., Tremblay J. P. Very efficient myoblast allotransplantation in mice under FK506 immunosuppression. Muscle Nerve. 1994 Dec;17(12):1407–1415. doi: 10.1002/mus.880171210. [DOI] [PubMed] [Google Scholar]
  22. Law P. K., Goodwin T. G., Li H. J. Histoincompatible myoblast injection improves muscle structure and function of dystrophic mice. Transplant Proc. 1988 Jun;20(3 Suppl 3):1114–1119. [PubMed] [Google Scholar]
  23. Law P. K., Goodwin T. G., Wang M. G. Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve. 1988 Jun;11(6):525–533. doi: 10.1002/mus.880110602. [DOI] [PubMed] [Google Scholar]
  24. Leivo I., Engvall E. Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle development. Proc Natl Acad Sci U S A. 1988 Mar;85(5):1544–1548. doi: 10.1073/pnas.85.5.1544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Lin Z., Lu M. H., Schultheiss T., Choi J., Holtzer S., DiLullo C., Fischman D. A., Holtzer H. Sequential appearance of muscle-specific proteins in myoblasts as a function of time after cell division: evidence for a conserved myoblast differentiation program in skeletal muscle. Cell Motil Cytoskeleton. 1994;29(1):1–19. doi: 10.1002/cm.970290102. [DOI] [PubMed] [Google Scholar]
  26. Madrid R. E., Jaros E., Cullen M. J., Bradley W. G. Genetically determined defect of Schwann cell basement membrane in dystrophic mouse. Nature. 1975 Sep 25;257(5524):319–321. doi: 10.1038/257319a0. [DOI] [PubMed] [Google Scholar]
  27. Michelson A. M., Russell E. S., Harman P. J. Dystrophia Muscularis: A HEREDITARY PRIMARY MYOPATHY IN THE HOUSE MOUSE. Proc Natl Acad Sci U S A. 1955 Dec 15;41(12):1079–1084. doi: 10.1073/pnas.41.12.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Montgomery A., Swenarchuk L. Dystrophic mice show age related muscle fibre and myelinated axon losses. Nature. 1977 May 12;267(5607):167–169. doi: 10.1038/267167a0. [DOI] [PubMed] [Google Scholar]
  29. Morgan J. E., Beauchamp J. R., Pagel C. N., Peckham M., Ataliotis P., Jat P. S., Noble M. D., Farmer K., Partridge T. A. Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines. Dev Biol. 1994 Apr;162(2):486–498. doi: 10.1006/dbio.1994.1103. [DOI] [PubMed] [Google Scholar]
  30. Morgan J. E., Hoffman E. P., Partridge T. A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J Cell Biol. 1990 Dec;111(6 Pt 1):2437–2449. doi: 10.1083/jcb.111.6.2437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Morgan J. E., Moore S. E., Walsh F. S., Partridge T. A. Formation of skeletal muscle in vivo from the mouse C2 cell line. J Cell Sci. 1992 Aug;102(Pt 4):779–787. doi: 10.1242/jcs.102.4.779. [DOI] [PubMed] [Google Scholar]
  32. Morgan J. E., Pagel C. N., Sherratt T., Partridge T. A. Long-term persistence and migration of myogenic cells injected into pre-irradiated muscles of mdx mice. J Neurol Sci. 1993 Apr;115(2):191–200. doi: 10.1016/0022-510x(93)90224-m. [DOI] [PubMed] [Google Scholar]
  33. Partridge T. A., Grounds M., Sloper J. C. Evidence of fusion between host and donor myoblasts in skeletal muscle grafts. Nature. 1978 May 25;273(5660):306–308. doi: 10.1038/273306a0. [DOI] [PubMed] [Google Scholar]
  34. Partridge T. A., Morgan J. E., Coulton G. R., Hoffman E. P., Kunkel L. M. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature. 1989 Jan 12;337(6203):176–179. doi: 10.1038/337176a0. [DOI] [PubMed] [Google Scholar]
  35. Pavlath G. K., Rando T. A., Blau H. M. Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J Cell Biol. 1994 Dec;127(6 Pt 2):1923–1932. doi: 10.1083/jcb.127.6.1923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Philpot J., Sewry C., Pennock J., Dubowitz V. Clinical phenotype in congenital muscular dystrophy: correlation with expression of merosin in skeletal muscle. Neuromuscul Disord. 1995 Jul;5(4):301–305. doi: 10.1016/0960-8966(94)00069-l. [DOI] [PubMed] [Google Scholar]
  37. Rantanen J., Hurme T., Lukka R., Heino J., Kalimo H. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab Invest. 1995 Mar;72(3):341–347. [PubMed] [Google Scholar]
  38. Sewry C. A., Philpot J., Mahony D., Wilson L. A., Muntoni F., Dubowitz V. Expression of laminin subunits in congenital muscular dystrophy. Neuromuscul Disord. 1995 Jul;5(4):307–316. doi: 10.1016/0960-8966(94)00072-h. [DOI] [PubMed] [Google Scholar]
  39. Sunada Y., Bernier S. M., Kozak C. A., Yamada Y., Campbell K. P. Deficiency of merosin in dystrophic dy mice and genetic linkage of laminin M chain gene to dy locus. J Biol Chem. 1994 May 13;269(19):13729–13732. [PubMed] [Google Scholar]
  40. Sunada Y., Bernier S. M., Utani A., Yamada Y., Campbell K. P. Identification of a novel mutant transcript of laminin alpha 2 chain gene responsible for muscular dystrophy and dysmyelination in dy2J mice. Hum Mol Genet. 1995 Jun;4(6):1055–1061. doi: 10.1093/hmg/4.6.1055. [DOI] [PubMed] [Google Scholar]
  41. Tomé F. M., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K. P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994 Apr;317(4):351–357. [PubMed] [Google Scholar]
  42. Tremblay J. P., Malouin F., Roy R., Huard J., Bouchard J. P., Satoh A., Richards C. L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 1993 Mar-Apr;2(2):99–112. doi: 10.1177/096368979300200203. [DOI] [PubMed] [Google Scholar]
  43. Vilquin J. T., Asselin I., Guérette B., Kinoshita I., Roy R., Tremblay J. P. Successful myoblast allotransplantation in mdx mice using rapamycin. Transplantation. 1995 Feb 15;59(3):422–426. [PubMed] [Google Scholar]
  44. Vilquin J. T., Guérette B., Kinoshita I., Roy B., Goulet M., Gravel C., Roy R., Tremblay J. P. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum Gene Ther. 1995 Nov;6(11):1391–1401. doi: 10.1089/hum.1995.6.11-1391. [DOI] [PubMed] [Google Scholar]
  45. Vilquin J. T., Wagner E., Kinoshita I., Roy R., Tremblay J. P. Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin. J Cell Biol. 1995 Nov;131(4):975–988. doi: 10.1083/jcb.131.4.975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Vuolteenaho R., Nissinen M., Sainio K., Byers M., Eddy R., Hirvonen H., Shows T. B., Sariola H., Engvall E., Tryggvason K. Human laminin M chain (merosin): complete primary structure, chromosomal assignment, and expression of the M and A chain in human fetal tissues. J Cell Biol. 1994 Feb;124(3):381–394. doi: 10.1083/jcb.124.3.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wakeford S., Watt D. J., Partridge T. A. X-irradiation improves mdx mouse muscle as a model of myofiber loss in DMD. Muscle Nerve. 1991 Jan;14(1):42–50. doi: 10.1002/mus.880140108. [DOI] [PubMed] [Google Scholar]
  48. Watt D. J., Morgan J. E., Partridge T. A. Long term survival of allografted muscle precursor cells following a limited period of treatment with cyclosporin A. Clin Exp Immunol. 1984 Feb;55(2):419–426. [PMC free article] [PubMed] [Google Scholar]
  49. Wernig A., Irintchev A., Härtling A., Stephan G., Zimmermann K., Starzinski-Powitz A. Formation of new muscle fibres and tumours after injection of cultured myogenic cells. J Neurocytol. 1991 Dec;20(12):982–997. doi: 10.1007/BF01187916. [DOI] [PubMed] [Google Scholar]
  50. Wirtz P., Loermans H., Rutten E. Effects of irradiation on regeneration in dystrophic mouse leg muscles. Br J Exp Pathol. 1982 Dec;63(6):671–679. [PMC free article] [PubMed] [Google Scholar]
  51. Xu H., Christmas P., Wu X. R., Wewer U. M., Engvall E. Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5572–5576. doi: 10.1073/pnas.91.12.5572. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Xu H., Wu X. R., Wewer U. M., Engvall E. Murine muscular dystrophy caused by a mutation in the laminin alpha 2 (Lama2) gene. Nat Genet. 1994 Nov;8(3):297–302. doi: 10.1038/ng1194-297. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES